annual operating profit:
-$535.97M+$33.23M(+5.84%)Summary
- As of today (July 6, 2025), RARE annual operating income is -$535.97 million, with the most recent change of +$33.23 million (+5.84%) on December 31, 2024.
- During the last 3 years, RARE annual operating profit has fallen by -$154.24 million (-40.40%).
- RARE annual operating profit is now -8069.07% below its all-time high of -$6.56 million, reached on December 31, 2011.
Performance
RARE Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$142.94M-$20.66M(-16.90%)Summary
- As of today (July 6, 2025), RARE quarterly operating income is -$142.94 million, with the most recent change of -$20.66 million (-16.90%) on March 31, 2025.
- Over the past year, RARE quarterly operating profit has increased by +$22.41 million (+13.55%).
- RARE quarterly operating profit is now -2955.56% below its all-time high of -$4.68 million, reached on December 31, 2012.
Performance
RARE quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$513.57M+$22.41M(+4.18%)Summary
- As of today (July 6, 2025), RARE TTM operating income is -$513.57 million, with the most recent change of +$22.41 million (+4.18%) on March 31, 2025.
- Over the past year, RARE TTM operating profit has increased by +$66.89 million (+11.52%).
- RARE TTM operating profit is now -10878.30% below its all-time high of -$4.68 million, reached on December 31, 2012.
Performance
RARE TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
RARE Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | +13.6% | +11.5% |
| 3 y3 years | -40.4% | -4.6% | -24.7% |
| 5 y5 years | -26.4% | -18.5% | -29.6% |
RARE Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | +17.4% | -22.8% | +36.5% | -9.1% | +23.7% |
| 5 y | 5-year | -62.4% | +17.4% | -184.1% | +36.5% | -62.5% | +23.7% |
| alltime | all time | -8069.1% | +17.4% | -2955.6% | +36.5% | <-9999.0% | +23.7% |
RARE Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$142.94M(+16.9%) | -$513.57M(-4.2%) |
| Dec 2024 | -$535.97M(-5.8%) | -$122.28M(-7.4%) | -$535.97M(+0.0%) |
| Sep 2024 | - | -$131.99M(+13.4%) | -$535.74M(-2.4%) |
| Jun 2024 | - | -$116.36M(-29.6%) | -$548.85M(-5.4%) |
| Mar 2024 | - | -$165.35M(+35.5%) | -$580.45M(+2.0%) |
| Dec 2023 | -$569.21M(-12.3%) | -$122.05M(-15.9%) | -$569.21M(-4.0%) |
| Sep 2023 | - | -$145.10M(-1.9%) | -$592.79M(-11.9%) |
| Jun 2023 | - | -$147.96M(-4.0%) | -$672.76M(+1.0%) |
| Mar 2023 | - | -$154.10M(+5.8%) | -$666.39M(+2.7%) |
| Dec 2022 | -$648.92M(+70.0%) | -$145.63M(-35.3%) | -$648.92M(+7.1%) |
| Sep 2022 | - | -$225.07M(+59.0%) | -$605.86M(+28.7%) |
| Jun 2022 | - | -$141.59M(+3.6%) | -$470.62M(+14.3%) |
| Mar 2022 | - | -$136.63M(+33.2%) | -$411.80M(+7.9%) |
| Dec 2021 | -$381.74M(+15.6%) | -$102.56M(+14.2%) | -$381.74M(+1.7%) |
| Sep 2021 | - | -$89.83M(+8.5%) | -$375.25M(+11.8%) |
| Jun 2021 | - | -$82.78M(-22.3%) | -$335.74M(+6.2%) |
| Mar 2021 | - | -$106.57M(+10.9%) | -$316.02M(-4.3%) |
| Dec 2020 | -$330.12M(-22.2%) | -$96.08M(+91.0%) | -$330.12M(+0.5%) |
| Sep 2020 | - | -$50.31M(-20.2%) | -$328.49M(-17.1%) |
| Jun 2020 | - | -$63.05M(-47.7%) | -$396.20M(-11.1%) |
| Mar 2020 | - | -$120.67M(+27.8%) | -$445.62M(+5.1%) |
| Dec 2019 | -$424.17M(+14.2%) | -$94.45M(-20.0%) | -$424.17M(+1.0%) |
| Sep 2019 | - | -$118.03M(+4.9%) | -$420.06M(+7.2%) |
| Jun 2019 | - | -$112.47M(+13.4%) | -$391.67M(+4.7%) |
| Mar 2019 | - | -$99.21M(+9.8%) | -$374.10M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$371.37M(+12.9%) | -$90.34M(+0.8%) | -$371.37M(-1.7%) |
| Sep 2018 | - | -$89.65M(-5.5%) | -$377.87M(+1.6%) |
| Jun 2018 | - | -$94.90M(-1.6%) | -$371.93M(+4.6%) |
| Mar 2018 | - | -$96.49M(-0.4%) | -$355.48M(+8.1%) |
| Dec 2017 | -$328.94M(+32.6%) | -$96.83M(+15.7%) | -$328.94M(+8.7%) |
| Sep 2017 | - | -$83.71M(+6.7%) | -$302.66M(+6.3%) |
| Jun 2017 | - | -$78.44M(+12.1%) | -$284.73M(+7.7%) |
| Mar 2017 | - | -$69.95M(-0.8%) | -$264.34M(+6.6%) |
| Dec 2016 | -$248.01M(+67.9%) | -$70.55M(+7.2%) | -$248.01M(+6.2%) |
| Sep 2016 | - | -$65.78M(+13.3%) | -$233.62M(+12.4%) |
| Jun 2016 | - | -$58.05M(+8.3%) | -$207.77M(+15.5%) |
| Mar 2016 | - | -$53.62M(-4.5%) | -$179.86M(+21.7%) |
| Dec 2015 | -$147.74M(+160.2%) | -$56.16M(+40.6%) | -$147.74M(+36.1%) |
| Sep 2015 | - | -$39.94M(+32.5%) | -$108.52M(+28.5%) |
| Jun 2015 | - | -$30.14M(+40.2%) | -$84.42M(+24.3%) |
| Mar 2015 | - | -$21.50M(+26.9%) | -$67.94M(+19.7%) |
| Dec 2014 | -$56.78M(+75.9%) | -$16.94M(+7.0%) | -$56.78M(+15.0%) |
| Sep 2014 | - | -$15.84M(+15.9%) | -$49.36M(+19.6%) |
| Jun 2014 | - | -$13.66M(+32.1%) | -$41.29M(+15.1%) |
| Mar 2014 | - | -$10.34M(+8.5%) | -$35.87M(+11.1%) |
| Dec 2013 | -$32.28M(+101.9%) | -$9.53M(+22.7%) | -$32.28M(+17.7%) |
| Sep 2013 | - | -$7.76M(-5.9%) | -$27.43M(+39.5%) |
| Jun 2013 | - | -$8.25M(+22.2%) | -$19.67M(+72.2%) |
| Mar 2013 | - | -$6.75M(+44.2%) | -$11.43M(+144.2%) |
| Dec 2012 | -$15.98M(+143.6%) | -$4.68M | -$4.68M |
| Dec 2011 | -$6.56M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual operating income?
- What is the all time high annual operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual operating profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly operating income?
- What is the all time high quarterly operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly operating profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM operating income?
- What is the all time high TTM operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM operating profit year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual operating income?
The current annual operating profit of RARE is -$535.97M
What is the all time high annual operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual operating income is -$6.56M
What is Ultragenyx Pharmaceutical Inc. annual operating profit year-on-year change?
Over the past year, RARE annual operating income has changed by +$33.23M (+5.84%)
What is Ultragenyx Pharmaceutical Inc. quarterly operating income?
The current quarterly operating profit of RARE is -$142.94M
What is the all time high quarterly operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly operating income is -$4.68M
What is Ultragenyx Pharmaceutical Inc. quarterly operating profit year-on-year change?
Over the past year, RARE quarterly operating income has changed by +$22.41M (+13.55%)
What is Ultragenyx Pharmaceutical Inc. TTM operating income?
The current TTM operating profit of RARE is -$513.57M
What is the all time high TTM operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM operating income is -$4.68M
What is Ultragenyx Pharmaceutical Inc. TTM operating profit year-on-year change?
Over the past year, RARE TTM operating income has changed by +$66.89M (+11.52%)